Starting August 1, 2024, Quickarrays Inc. will be taking over Pantomics Inc. to
provide all products and services. Please visit Quickarrays Inc. for more information.
SERVICES
CUSTOM TMA
ROUTINE PATHOLOGY
IHC / IMMUNOFLUORESCENCE
ISH / FISH
CONTRACTED SERVICES
PRIMARY IHC ANTIBODIES
PATHOLOGY FIELD
DETECTION SYSTEMS
ANCILLARIES
CONTROL TMA
Hermatopathology
LUM961
Lung cancer tissue array containing paired primary and metastatic tumors (in lymph nodes and other organs) from the same patients, 96 cores, 48 cases
Specification
Data Sheet
TNM Grading
Downloads
Price
Size
Availability
$448
1 slide
In-Stock
A | |
B | |
C | |
D | |
E | |
F | |
G | |
H | |
TNM Classification: Lung carcinoma
T- Primary tumor
TX - Primary tumor cannot be assessed or tumor proven by the presence of malignant cell in sputum or bronchial washing but not visualized by imaging of bronchoscopy;
TO - No evidence of primary tumor;
Tis- Carcinoma in situ;
T1 - Tumor 3 cm or less in greatest dimension, surrounded by lung or visceral pleura without bronchoscopic evidence of invasion more proximal than lobular bronchus;
T2 - Tumor with any of the following features of size or extent; more than 3 cm in greatest dimension; involves main bronchus, 2 cm more proximal to carina; invades visceral pleura; associated with atelectasis or obstructive pneumonitis that extends to the hilar region but not involve the entire lung;
T3 - Tumor of any size that directly invades any of the followings: chest wall (including superior sulcus tumor), diaphragm, mediastinal pleura, parietal pericardium; tumors in the main bronchus less than 3 cm distal to the carina; associated with atelectasis or obstructive pneumonitis of entire lung;
T4 - Tumor of any size that invades any of the following: mediastinum, heart, great vessel, trachea, esophagus, vertebral body, carina, separate tumor nodule(s) in the same,lobe; tumor with malignant pleural effusion.
N - Regional lymph nodes
NX - Regional lymph nodes cannot be assessed;
NO - No regional lymph node metastasis;
N1 - Metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary nodes, including involvement by direct extension;
N2 - Metastasis in ipsilateral mediastinal and/or subcarinal lymph nodes;
N3 - Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or contralateral, scalene, or supraclavicular lymph nodes.
M - Distant metastasis
MX - Distant metastasis cannot be assessed MO - No distant metastasis;
M1 - Distant metastasis, including separate tumor nodule(s) in a different lobe (ipsilateral or contralateral).
Human
48
96
1.5mm
4um
8
12
Paraffin
Notes:
All tissues were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or Startfrost Adhesive slides. They all have a guaranteed six month shelf-life at 4C from the date of shipment. Additional cores not listed are orientation markers and have no data. There maybe <5% core loss per slide but the core retention rate should be >90%.
Bake at 60C for 30 minutes before use. If antigen retrieving is needed, it is always a good idea to start with a protocol with weak to mild strength. Please check our TNM guide as a reference. For IHC related information on products that provide them, please contact us at info@pantomics.com for the most up-to-date information.
For research use only. Designed for comparative IHC or ISH based protein or RNA tissue profiling in paired primary and metastatic tumor tissues from multiple lung cancer patients.
ARRAY POSITION | IMAGE | SEX | AGE | ANATOMIC SITE | PATHOLOGY | GRADE | STAGE (TNM) |
|---|---|---|---|---|---|---|---|
A01 | M | 44 | Lung | Adenosquamous carcinoma | II | T2N1M0 | |
A02 | F | 75 | Lung | Adenosquamous carcinoma | II | T2N0M0 | |
A03 | M | 69 | Lung | Adenomcarcinoma | II | T2N1M0 | |
A04 | F | 67 | Lung | Adenosquamous carcinoma | I | T2N1M0 | |
A05 | M | 51 | Lung | Squamous cell carcinoma | II | T2N1M0 | |
A06 | M | 68 | Lung | Adenosquamous carcinoma | III | T2N1M0 | |
A07 | M | 62 | Lung | Squamous cell carcinoma | III | T2N1M0 | |
A08 | M | 64 | Lung | Undifferentiated carcinoma | III~IV | T2N1M0 | |
A09 | F | 51 | Lung | Large cell carcinoma | IV | T2N2M0 | |
A10 | F | 40 | Lung | Squamous cell carcinoma | III | T2N1M0 | |
A11 | F | 58 | Lung | Adenomcarcinoma | III | T2N1M0 | |
A12 | M | 76 | Lung | Squamous cell carcinoma | III | T2N1M0 | |
B01 | M | 44 | Lung | Uninvolved lung tissue of A01 | |||
B02 | F | 75 | Lung | Uninvolved lung tissue of A02 | |||
B03 | M | 69 | Lung | Uninvolved lung tissue of A03 | |||
B04 | F | 67 | Lung | Uninvolved lung tissue of A04 | |||
B05 | M | 51 | Lung | Uninvolved lung tissue of A05 | |||
B06 | M | 68 | Lung | Uninvolved lung tissue of A06 | |||
B07 | M | 62 | Lung | Uninvolved lung tissue of A07 | |||
B08 | M | 64 | Lymph node | Lymph node metastasis of A08 | |||
B09 | F | 51 | Lymph node | Lymph node metastasis of A09 | |||
B10 | F | 40 | Lymph node | Lymph node metastasis of A10 | |||
B11 | F | 58 | Lymph node | Lymph node metastasis of A11 | |||
B12 | M | 76 | Lymph node | Lymph node metastasis of A12 | |||
C01 | M | 53 | Lung | Squamous cell carcinoma | III | T2N1M0 | |
C02 | M | 42 | Lung | Small cell carcinoma | T2N1M0 | ||
C03 | F | 43 | Lung | Squamous cell carcinoma | II~III | T2N1M0 | |
C04 | F | 60 | Lung | Adenosquamous carcinoma | II | T2N1M0 | |
C05 | M | 53 | Lung | Adenomcarcinoma | III | T2N1M0 | |
C06 | M | 59 | Lung | Adenomcarcinoma | III | T2N1M0 | |
C07 | M | 72 | Lung | Adenomcarcinoma | III | T2N2M0 | |
C08 | M | 52 | Lung | Squamous cell carcinoma | II | T2N1M0 | |
C09 | M | 56 | Lung | Adenomcarcinoma | II | T2N1M0 | |
C10 | M | 60 | Lung | Squamous cell carcinoma | II | T1N1M0 | |
C11 | F | 55 | Lung | Adenomcarcinoma | II | T3N1M1 | |
C12 | M | 54 | Lung | Squamous cell carcinoma | III | T2N1M1 | |
D01 | M | 53 | Lymph node | Lymph node metastasis of C01 | |||
D02 | M | 42 | Lymph node | Lymph node metastasis of C02 | |||
D03 | F | 43 | Lymph node | Lymph node metastasis of C03 | |||
D04 | F | 60 | Lymph node | Lymph node metastasis of C04 | |||
D05 | M | 53 | Lymph node | Lymph node metastasis of C05 | |||
D06 | M | 59 | Lymph node | Lymph node metastasis of C06 | |||
D07 | M | 72 | Lymph node | Lymph node metastasis of C07 | |||
D08 | M | 52 | Lymph node | Lymph node metastasis of C08 | |||
D09 | M | 56 | Lymph node | Lymph node metastasis of C09 | |||
D10 | M | 60 | Lymph node | Lymph node metastasis of C10 | |||
D11 | F | 55 | Lymph node | Lymph node metastasis of C11 | |||
D12 | M | 54 | Lymph node | Lymph node metastasis of C12 | |||
E01 | F | 57 | Lung | Adenomcarcinoma | II | T1N1M0 | |
E02 | M | 70 | Lung | Adenomcarcinoma | III | T2N1M0 | |
E03 | M | 56 | Lung | Adenomcarcinoma | II | T2N1M0 | |
E04 | M | 52 | Lung | Adenomcarcinoma | I-II | T2N1M0 | |
E05 | M | 73 | Lung | Adenosquamous carcinoma | II-III | T3N1M0 | |
E06 | M | 63 | Lung | Adenomcarcinoma | II | T2N1M0 | |
E07 | M | 51 | Lung | Squamous cell carcinoma | II-III | T2N1M0 | |
E08 | M | 63 | Lung | Squamous cell carcinoma | II | T2N1M0 | |
E09 | F | 57 | Lung | Adenomcarcinoma | II | T2N1M0 | |
E10 | M | 64 | Lung | Squamous cell carcinoma | II | T2N1M0 | |
E11 | M | 63 | Lung | Adenomcarcinoma | II | T2N1M0 | |
E12 | M | 52 | Lung | Squamous cell carcinoma | III | T2N1M0 | |
F01 | F | 57 | Lymph node | Lymph node metastasis of E01 | |||
F02 | M | 70 | Lymph node | Lymph node metastasis of E02 | |||
F03 | M | 56 | Lymph node | Lymph node metastasis of E03 | |||
F04 | M | 52 | Lymph node | Lymph node metastasis of E04 | |||
F05 | M | 73 | Lymph node | Lymph node metastasis of E05 | |||
F06 | M | 63 | Lymph node | Lymph node metastasis of E06 | |||
F07 | M | 51 | Lymph node | Lymph node metastasis of E07 | |||
F08 | M | 63 | Lymph node | Lymph node metastasis of E08 | |||
F09 | F | 57 | Lymph node | Lymph node metastasis of E09 | |||
F10 | M | 64 | Lymph node | Lymph node metastasis of E10 | |||
F11 | M | 63 | Lymph node | Lymph node metastasis of E11 | |||
F12 | M | 52 | Lymph node | Lymph node metastasis of E12 | |||
G01 | M | 60 | Lung | Squamous cell carcinoma | II-III | T2N1M0 | |
G02 | M | 62 | Lung | Squamous cell carcinoma | I-II | T2N1M0 | |
G03 | M | 73 | Lung | Squamous cell carcinoma | II-III | T2N1M0 | |
G04 | M | 64 | Lung | Squamous cell carcinoma | II | T3N1M0 | |
G05 | M | 66 | Lung | Squamous cell carcinoma | I-II | T2N1M0 | |
G06 | M | 62 | Lung | Squamous cell carcinoma | III | T2N1M0 | |
G07 | M | 62 | Lung | Squamous cell carcinoma | I-II | T2N1M0 | |
G08 | M | 52 | Lung | Squamous cell carcinoma | I | T2N2M0 | |
G09 | F | 62 | Lung | Adenosquamous carcinoma | I-II | T3N1M0 | |
G10 | F | 51 | Lung | Adenomcarcinoma | II | T2N1M0 | |
G11 | M | 52 | Lung | Adenomcarcinoma | II | T2N1M0 | |
G12 | M | 70 | Lung | Squamous cell carcinoma | I-II | T2N1M0 | |
H01 | M | 60 | Lymph node | Lymph node metastasis of G01 | |||
H02 | M | 62 | Lymph node | Lymph node metastasis of G02 | |||
H03 | M | 73 | Lymph node | Lymph node metastasis of G03 | |||
H04 | M | 64 | Lymph node | Lymph node metastasis of G04 | |||
H05 | M | 66 | Lymph node | Lymph node metastasis of G05 | |||
H06 | M | 62 | Lymph node | Lymph node metastasis of G06 | |||
H07 | M | 62 | Lymph node | Lymph node metastasis of G07 | |||
H08 | M | 52 | Lymph node | Lymph node metastasis of G08 | |||
H09 | F | 62 | Lymph node | Lymph node metastasis of G09 | |||
H10 | F | 51 | Lymph node | Lymph node metastasis of G10 | |||
H11 | M | 52 | Lymph node | Lymph node metastasis of G11 | |||
H12 | M | 70 | Lymph node | Lymph node metastasis of G12 | |||
null |
